drugset / Trial / NCT07288333
Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective for this study is to evaluate the efficacy of NBI-1117570 compared with placebo on improving behavioral and psychological symptoms of schizophrenia in adults who warrant inpatient hospitalization.
Timeline
- Start
- 2026-02-16
- Primary completion
- 2027-08
- Completion
- 2027-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NBI-1117570 | Unknown | — | Oral |